Gut microbiota, endothelial dysfunction and tau-mediated cognitive impairment

Guiseppe Faraco

Dr. Giuseppe Faraco received a grant from Cure Alzheimer’s Fund titled “Gut microbiota, endothelial dysfunction and tau-mediated cognitive impairment”. The grant aims at elucidating the link between microbiota-induced dysregulation of gut immunity, tau pathology & cognitive impairment.

Contract Supports Research into Personalized Treatments for Depression

a man smiling for a photo

A three-year contract from Wellcome Leap will allow a team of investigators from Weill Cornell Medicine, Stanford Medicine and UC San Diego School of Medicine to study new ways to combat depression and create models that can predict which treatment is likely to work for individual patients.

“The purpose of this project is to develop new approaches to treating depression that work more effectively and in a more personalized way,” said principal investigator...

Read More

Mapping Dementia-Linked Protein Interactions Yields Potential New Treatment Targets

Abstract illustration of a brain

By mapping all the protein interactions of a dementia-linked protein in the brain called Tau, a team of Weill Cornell Medicine investigators has created a road map for identifying potential new treatment targets for Alzheimer’s disease and related dementia.

Tau protein has long been implicated in neurodegenerative diseases. Mutations in the gene that encodes the Tau protein result in neurodegenerative...

Read More

“Mini-Brains” Provide Clues About Early Life Origins of Schizophrenia

microscopic image mini brian

Multiple changes in brain cells during the first month of embryonic development may contribute to schizophrenia later in life, according to a new study by Weill Cornell Medicine investigators.

The researchers, whose study was published in Molecular Psychiatry on Nov. 17, used stem cells collected from patients with schizophrenia and people without the disease to grow 3-dimensional “mini-brains” or organoids in the...

Read More

Researchers Develop New Approach to Analyzing Complex Genetics Underlying Spina Bifida

Dr. Elizabeth Ross

Weill Cornell Medicine researchers are using machine learning, a form of artificial intelligence, to shed light on genetic mutations associated with spina bifida. In this birth defect, the neural tube that forms the spinal cord during pregnancy, does not close so that spinal nerves are exposed, resulting in paralysis and high risk of other complications.

Their new study, published online Dec. 16 in PNAS, “brings us closer to...

Read More

Novel Immune Cell Population May Trigger Inflammation in Multiple Sclerosis and other Brain Disorders

Inflammatory immune cells in the spinal cord of mouse

A group of immune cells that normally protect against inflammation in the gastrointestinal tract may have the opposite effect in multiple sclerosis (MS) and other brain inflammation-related conditions, according to a new study by Weill Cornell Medicine and NewYork-Presbyterian researchers. The results suggest that countering the activity of these cells could be a new therapeutic approach for such conditions.


Read More

Targeting the Brain’s Immune Cells May Help Prevent or Treat Alzheimer’s Disease

multicolor dots representing different microglial cell states

A gene mutation linked to Alzheimer’s disease alters a signaling pathway in certain immune cells of individuals with the disease, according to a new study by scientists at Weill Cornell Medicine. The team also found that blocking the pathway—with a drug that’s currently being tested in cancer clinical trials—protects against many features of the condition in a preclinical model. The results could lead to new strategies to...

Read More

Department of Defense Funds Research on Rare Eye Condition

a woman smiling for a portrait

Weill Cornell Medicine has received a $1.27 million grant from the United States Department of Defense (DoD) to develop treatment for a rare but devastating eye condition largely affecting military personnel who suffer traumatic eye injuries in combat.

Under the three-year grant, investigators will test the safety and effectiveness of two newly developed antibodies to treat proliferative vitreoretinopathy, or PVR. Currently not treatable or preventable,...

Read More

Annual Appel Alzheimer's Disease Research Institute Symposium Highlights Latest Research in Dementia

brain illustration

Some of the latest research discoveries in neurodegenerative disease and their potential therapeutic applications were featured at the ninth annual Appel Alzheimer's Disease Research Institute Symposium, held remotely on Nov. 9. 

Sponsored by Weill Cornell Medicine’s Helen and Robert Appel Alzheimer’s Disease Research Institute and its home department, the Feil Family Brain...

Read More

Dr. Costantino Iadecola Wins the American Heart Association’s 2021 Basic Research Prize

a man in a suit posing for a picture

Dr. Costantino Iadecola, director and chair of the Feil Family Brain and Mind Research Institute and the Anne Parrish Titzell Professor of Neurology at Weill Cornell Medicine, has been awarded the 2021 Basic Research Prize from the American Heart Association (AHA).

The AHA Basic Research Prize is given annually to an individual in recognition...

Read More

Weill Cornell Medicine Feil Family Brain & Mind Research Institute 407 E 61st St New York, NY 10065 Phone: (646) 962-8277 Fax: (646) 962-0535